Trevi Therapeutics Management
Management criteria checks 3/4
Trevi Therapeutics' CEO is Jennifer Good, appointed in Mar 2011, has a tenure of 13.17 years. total yearly compensation is $1.69M, comprised of 35.4% salary and 64.6% bonuses, including company stock and options. directly owns 0.3% of the company’s shares, worth $604.66K. The average tenure of the management team and the board of directors is 3.1 years and 6.8 years respectively.
Key information
Jennifer Good
Chief executive officer
US$1.7m
Total compensation
| CEO salary percentage | 35.4% |
| CEO tenure | 13.2yrs |
| CEO ownership | 0.3% |
| Management average tenure | 3.1yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$597k | -US$29m |
| Sep 30 2023 | n/a | n/a | -US$27m |
| Jun 30 2023 | n/a | n/a | -US$27m |
| Mar 31 2023 | n/a | n/a | -US$28m |
| Dec 31 2022 | US$898k | US$523k | -US$29m |
| Sep 30 2022 | n/a | n/a | -US$32m |
| Jun 30 2022 | n/a | n/a | -US$31m |
| Mar 31 2022 | n/a | n/a | -US$33m |
| Dec 31 2021 | US$2m | US$506k | -US$34m |
| Sep 30 2021 | n/a | n/a | -US$35m |
| Jun 30 2021 | n/a | n/a | -US$35m |
| Mar 31 2021 | n/a | n/a | -US$33m |
| Dec 31 2020 | US$1m | US$478k | -US$33m |
| Sep 30 2020 | n/a | n/a | -US$30m |
| Jun 30 2020 | n/a | n/a | -US$30m |
| Mar 31 2020 | n/a | n/a | -US$29m |
| Dec 31 2019 | US$3m | US$435k | -US$27m |
| Sep 30 2019 | n/a | n/a | -US$28m |
| Jun 30 2019 | n/a | n/a | -US$27m |
| Mar 31 2019 | n/a | n/a | -US$27m |
| Dec 31 2018 | US$528k | US$400k | -US$26m |
| Sep 30 2018 | n/a | n/a | -US$22m |
| Dec 31 2017 | US$865k | US$367k | -US$13m |
Compensation vs Market: Jennifer's total compensation ($USD1.69M) is about average for companies of similar size in the US market ($USD1.62M).
Compensation vs Earnings: Jennifer's compensation has increased whilst the company is unprofitable.
CEO
Jennifer Good (58 yo)
13.2yrs
Tenure
US$1,687,298
Compensation
Ms. Jennifer L. Good co-founded Trevi Therapeutics, Inc., in March 2011 and has been its Chief Executive Officer and President since March 2011. Ms. Good served as Principal Financial Officer at Trevi Ther...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.2yrs | US$1.69m | 0.30% $ 604.7k | |
| Co-Founder & Chief Scientific Officer | 13.2yrs | US$977.13k | 0.29% $ 585.3k | |
| Chief Medical Officer | 1.5yrs | US$610.64k | no data | |
| Chief Financial Officer | 2.8yrs | no data | 0.051% $ 102.7k | |
| Controller & Chief Accounting Officer | 3.1yrs | no data | no data | |
| Communications Manager | no data | no data | no data | |
| Chief Commercial Officer | no data | no data | 0.065% $ 130.6k | |
| Vice President of Medical Affairs | no data | no data | no data |
3.1yrs
Average Tenure
58yo
Average Age
Experienced Management: TRVI's management team is considered experienced (3.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.2yrs | US$1.69m | 0.30% $ 604.7k | |
| Independent Director | 4.3yrs | US$112.95k | 0% $ 0 | |
| Independent Director | 5.6yrs | US$127.95k | 0.037% $ 74.3k | |
| Independent Director | 3.9yrs | US$120.45k | 0% $ 0 | |
| Independent Director | 6.8yrs | US$110.45k | 0% $ 0 | |
| Independent Chairman of the Board | 6.8yrs | US$135.45k | 0.50% $ 1.0m | |
| Independent Director | 7.3yrs | US$127.95k | 0.0090% $ 18.2k | |
| Member of Clinical Advisory Board | 11.2yrs | no data | no data | |
| Member of Clinical Advisory Board | 11.2yrs | no data | no data |
6.8yrs
Average Tenure
63yo
Average Age
Experienced Board: TRVI's board of directors are considered experienced (6.8 years average tenure).